A detailed history of Pnc Financial Services Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 33,999 shares of MRNA stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,999
Previous 41,235 17.55%
Holding current value
$1.25 Million
Previous $4.9 Million 53.59%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$63.64 - $125.14 $460,499 - $905,513
-7,236 Reduced 17.55%
33,999 $2.27 Million
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $479,026 - $788,565
4,733 Added 12.97%
41,235 $4.9 Million
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $820,576 - $1.11 Million
9,612 Added 35.75%
36,502 $3.89 Million
Q4 2023

Feb 09, 2024

SELL
$69.51 - $104.43 $56,233 - $84,483
-809 Reduced 2.92%
26,890 $2.67 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $213,066 - $279,808
-2,210 Reduced 7.39%
27,699 $2.86 Million
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $28,914 - $39,169
244 Added 0.82%
29,909 $3.63 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $1.34 Million - $1.94 Million
-9,845 Reduced 24.92%
29,665 $4.56 Million
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $5,682 - $10,081
48 Added 0.12%
39,510 $7.1 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $1.24 Million - $2.04 Million
10,526 Added 36.38%
39,462 $4.67 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $563,043 - $848,868
4,807 Added 19.92%
28,936 $4.13 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $521,268 - $968,876
4,122 Added 20.6%
24,129 $4.16 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $836,888 - $1.37 Million
-3,706 Reduced 15.63%
20,007 $5.08 Million
Q3 2021

Nov 05, 2021

BUY
$221.9 - $484.47 $1.76 Million - $3.85 Million
7,943 Added 50.37%
23,713 $9.13 Million
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $113,541 - $205,372
874 Added 5.87%
15,770 $3.71 Million
Q1 2021

May 07, 2021

SELL
$109.18 - $185.98 $21,836 - $37,196
-200 Reduced 1.32%
14,896 $1.95 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $226,277 - $584,658
3,442 Added 29.53%
15,096 $1.58 Million
Q3 2020

Nov 06, 2020

BUY
$54.34 - $94.85 $37,983 - $66,300
699 Added 6.38%
11,654 $824,000
Q2 2020

Aug 07, 2020

BUY
$29.67 - $80.0 $199,590 - $538,160
6,727 Added 159.11%
10,955 $703,000
Q1 2020

May 08, 2020

BUY
$17.78 - $31.58 $1,262 - $2,242
71 Added 1.71%
4,228 $126,000
Q4 2019

Feb 07, 2020

BUY
$13.93 - $21.28 $24,405 - $37,282
1,752 Added 72.85%
4,157 $81,000
Q3 2019

Nov 08, 2019

BUY
$12.26 - $18.07 $2,353 - $3,469
192 Added 8.68%
2,405 $38,000
Q2 2019

Aug 09, 2019

BUY
$13.7 - $28.34 $30,318 - $62,716
2,213 New
2,213 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.